'In-Format' screening of a novel bispecific antibody format reveals significant potency improvements relative to unformatted molecules.
Ontology highlight
ABSTRACT: Bispecific antibodies (BsAbs) are emerging as an important class of biopharmaceutical. The majority of BsAbs are created from conventional antibodies or fragments engineered into more complex configurations. A recurring challenge in their development, however, is the identification of components that are optimised for inclusion in the final format in order to deliver both efficacy and robust biophysical properties. Using a modular BsAb format, the mAb-dAb, we assessed whether an 'in-format' screening approach, designed to select format-compatible domain antibodies, could expedite lead discovery. Human nerve growth factor (NGF) was selected as an antigen to validate the approach; domain antibody (dAb) libraries were screened, panels of binders identified, and binding affinities and potencie
SUBMITTER: Scott MJ
PROVIDER: S-EPMC5240641 | biostudies-literature | 2017 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA